About the
NeLM
|
Help & Support
|
Site Feedback
|
Update Newsletter Subscription
Homepage
Login
|
Register
Search the NeLM
Medicines A-Z
Find key information about medicines by name (prototype)
Browse by Categories:
BNF Category
|
Medical Specialty
|
National Health Service
|
Medicines Information
Browse by NeLM area:
Evidence
|
Other Library Updates
|
News
|
Health In Focus
|
Medicines A-Z
|
Communities
|
Useful Links
|
Formularies
Medical Specialty
Anaesthesia
Bone Diseases
Cardiovascular Medicine
Care of Older People
Cerebrovascular Disorders
Complementary Medicine
Dentistry
Dermatology
Ear, Nose and Throat (ENT) disorders
Emergency Medicine
Endocrinology
Family planning
Gastroenterology
Geriatric Medicine
Haematology
Immunology and vaccination
Infections
Infectious Diseases
Intensive Care (ICU)
Liver disease
Menopause / hormone replacement therapy (HRT)
Mental Health
Neurology
Nutrition and Metabolism
Obstetrics & Gynaecology
Oncology
Ophthalmology
Paediatrics
Pain control
Palliative care
Preventative medicines
Radiology
Renal medicine
Reproductive medicine
Respiratory Medicine
Rheumatology
Sports medicine
Surgery
Travel medicine
Urology
Wound Management
Cancer: bladder
Cancer: brain
Cancer: breast
Cancer: gastroenterological
Cancer: gynaecological
Cancer: haematological
Cancer: kidney
Cancer: lung
Cancer: other
Cancer: pancreas
Cancer: prostate
Cancer: skin
Leukaemia
Lymphoma
Radiotherapy
112 library items
in Cancer: kidney
Filter results by:
Date Published
2012 (3)
2011 (14)
2010 (23)
2009 (35)
2008 (19)
More
NeLM
Area
News
Other Library Updates
Health In Focus
Evidence
Medicines A-Z
Communities
Formularies
Results filtered by:
Category
Oncology (
remove
)
,
Cancer: kidney (
remove
)
Sort by:
Least recent publication date
Most recent publication date
Title alphabetical A-Z
Title alphabetical Z-A
Source alphabetical A-Z
Source alphabetical Z-A
Display summary:
No
Yes
Results 1 - 10 of 112
Result page:
Previous
|
1
2
3
4
5
6
7
8
9
10
11
|
Next
1.
Intravesical gemcitabine for non-muscle invasive bladder cancer
Source:
Cochrane Library
,
Date published:
05/02/2012
Category:
8.1.3 Antimetabolites
|
Cancer: kidney
|
Drug reviews
NeLM
Area:
Evidence
>
Drug Specific Reviews
Link to Abstract
2.
FDA approves axitinib (Inlyta®) for advanced kidney cancer
Source:
PharmaTimes
,
Date published:
30/01/2012
Category:
8.1.5 Other antineoplastic drugs
|
Cancer: kidney
|
Food &Drug Administration (FDA)
NeLM
Area:
News
Link (Free registration required)
AXIS study results (NeLM report)
3.
Horizon scanning: Tivozanib demonstrates superior PFS over sorafenib in advanced renal cell cancer
Source:
PharmaLive
,
Date published:
04/01/2012
Category:
8.1.5 Other antineoplastic drugs
|
Cancer: kidney
|
Horizon scanning
NeLM
Area:
News
Link
4.
Horizon scanning: FDA advisory panel supports licensing of axitinib for advanced kidney cancer in US
Source:
Reuters
,
Date published:
08/12/2011
Category:
8.1.5 Other antineoplastic drugs
|
Cancer: kidney
|
Food &Drug Administration (FDA)
|
New drugs
NeLM
Area:
News
Link
5.
DTB: Tyrosine kinase inhibitors for metastatic renal cell carcinoma
Source:
Drug and Therapeutics Bulletin (DTB)
,
Date published:
11/11/2011
Category:
8.1.5 Other antineoplastic drugs
|
Cancer: kidney
|
Drug reviews
NeLM
Area:
Evidence
>
Drug Specific Reviews
Abstract
6.
Horizon scanning: Study finds two polymorphisms that may be associated with sunitinib tolerability and response in RCC
Source:
Lancet Oncology
,
Date published:
18/10/2011
Category:
8.1.5 Other antineoplastic drugs
|
Cancer: kidney
NeLM
Area:
News
Link (abstract)
Comment
7.
Long-term use of non-aspirin NSAIDs may increase risk of renal cell cancer?
Source:
Arch Internal Med
,
Date published:
13/09/2011
Category:
4.7.1 Non-opioid analgesics and compound analgesic preparations
|
10.1.1 Non-steroidal anti-inflammatory drugs
|
Adverse Drug Reactions
|
Cancer: kidney
NeLM
Area:
News
Link (abstract)
Comment (extract)
Link to NHS Choices ‘Behind the Headlines’ service
8.
Temsirolimus and bevacizumab, or sunitinib, or interferon alfa and bevacizumab for patients with advanced renal cell carcinoma (TORAVA)
Source:
Lancet Oncology
,
Date published:
10/06/2011
Category:
8.1.5 Other antineoplastic drugs
|
Cancer: kidney
NeLM
Area:
News
Study abstract
Comment (full text – available freely at time of posting)
9.
Axitinib submitted to EMA for regulatory review
Source:
BioSpace.com
,
Date published:
02/06/2011
Category:
Cancer: kidney
|
European Agency for the Evaluation of Medicinal Products (EMEA)
|
New drugs
NeLM
Area:
News
BioSpace story
10.
Conference report: Axitinib superior to sorafenib for relapsed RCC?
Source:
BioSpace
,
Date published:
23/05/2011
Category:
8.1.5 Other antineoplastic drugs
|
Cancer: kidney
|
New drugs
NeLM
Area:
News
Link
Results 1 - 10 of 112
Result page:
Previous
|
1
2
3
4
5
6
7
8
9
10
11
|
Next